Loading...
A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
OBJECTIVES: This study assessed the efficacy and safety of plecanatide, a guanylate cyclase-C (GC-C) agonist and the first uroguanylin analog approved for the treatment of chronic idiopathic constipation (CIC). METHODS: This phase III, multicenter, double-blind, placebo-controlled study randomized 1...
Na minha lista:
Udgivet i: | Am J Gastroenterol |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5415706/ https://ncbi.nlm.nih.gov/pubmed/28169285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2016.611 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|